| Dear Colleagues, Interasma Scientific Network (INES) invite you to complete this survey, leaded by Prof. Angelica Tiotiu which aims to “identify 5 criteria to use in practice for the evaluation of the response to biologics in asthma at 4 months of treatment”. Compilation takes a maximum of 5 minutes and your choices will be anonymous unless you will select to be involved in the scientific dissemination. Contact e-mail: inesnetwork@interasma.org Your participation in this study is completely voluntary. If you choose to participate, you may choose to discontinue participation at any time, and you may choose any of the survey questions that you do not wish to answer. Your completion of the survey must be made until August 8th, 2022. Sincerely,Angelica Tiotiu MD PhD, Pulmonologist, Allergologist in the Department of Pulmonology, University Hospital of Nancy, France |
Recent Posts
- CXCL16 knockout inhibit asthma airway inflammation by suppressing H2-DM molecular mediated antigen presentation
- Exposure to volatile organic compounds and chronic respiratory disease mortality, a case-cohort study
- Beneficial effects of pleuran on asthma control and respiratory tract-infection frequency in children with perennial asthma
- Microbial influencers: the airway microbiome’s role in asthma
- Lung CD4+ resident memory T cells use airway secretory cells to stimulate and regulate onset of allergic airway neutrophilic disease